Liver cancer is the third leading cause of cancer death, with high incidence and poor
treatment effect. In recent years, polysaccharides have attracted more and more attention in …

Background The second leading cause of mortality in the world, behind cardiovascular
disorders, is cancer. The currently employed treatment options including radiotherapy …

Liver metastasis is a major obstacle in treating aggressive cancers, and current therapeutic
options often prove insufficient. To overcome these challenges, there has been growing …

Background In this present work we are aiming to develop an Ag 2 SnO 3 based
electrochemical sensor for the detection of kinase inhibitor sorafenib (SRF). The detection of …

In the dynamic landscape of pharmaceutical advancements, the strategic application of
active pharmaceutical ingredients to the skin through topical and transdermal routes has …

Hepatocellular Carcinoma is one of the detrimental forms of liver cancer perceived to be the
fourth most dangerous disease on a global forum. The prevalence of HCC is increasing day …

Background Liver and breast cancers are among the leading causes of cancer-related
deaths worldwide, prompting researchers to seek natural anticancer agents and reduce …

In this work, we describe the development of targeted polymeric nanoparticles loaded with
lenvatinib for the treatment of hepatocellular carcinoma (HCC). A synthetic brush copolymer …

Cholic acid based biodegradable reverse polymeric micelles have been widely utilized as
preclinically suitable drug delivery system for poorly water-soluble drugs. In this report, we …

Nanoparticle-based medicines have emerged as promising cancer therapy techniques,
providing tailored administration, increased efficacy, and lower systemic toxicity than …